$PROF·8-K

Profound Medical Corp. · Jul 16, 4:45 PM ET

Compare

Profound Medical Corp. 8-K

Research Summary

AI-generated summary

Updated

Profound Medical Corp. Announces Q2 2026 Results Release and Call

What Happened
Profound Medical Corp. (PROF) filed a Form 8-K (Regulation FD disclosure) on July 16, 2026 announcing it will release its second-quarter 2026 financial results after market close on Thursday, August 6, 2026. The company also said it will host a conference call and webcast to review the results and discuss business developments at 4:30 p.m. Eastern Time on the same day. A press release with access details was furnished as Exhibit 99.1 to the 8-K. The filing was signed by Chief Financial Officer Rashed Dewan.

Key Details

  • Release date: Q2 2026 results to be released after market close on Thursday, August 6, 2026.
  • Conference call: Scheduled for 4:30 p.m. Eastern Time on August 6, 2026 (call and webcast).
  • Disclosure: Announcement made via press release dated July 16, 2026 (Exhibit 99.1 to the 8-K).
  • Filed under Item 7.01 (Regulation FD Disclosure); filing signed by CFO Rashed Dewan on July 16, 2026.

Why It Matters
This notice gives investors the date and time to hear Profound’s quarterly earnings, revenue and other financial results and management commentary. Knowing the exact release and call schedule lets shareholders and analysts plan to review the results, ask questions on the call, and react to any new financial or business information when it is published.

Loading document...